Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination
Robert M. A. Hirschfeld(The University of Texas Medical Branch at Galveston), Martín Keller(University of Basel), Daniel N. Klein(Stony Brook University), Frances E. Borian, Charles B. Nemeroff(The University of Texas at Austin), Alan F. Schatzberg(Stanford University), Paul Crits‐Christoph(University of Pennsylvania), Susan G. Kornstein(Virginia Commonwealth University), Philip T. Ninan(Emory University), John C. Markowitz(New York Psychoanalytic Society and Institute), David L. Dünner, Madhukar H. Trivedi(Southwestern Medical Center), Ivan Miller, Michael E. Thase(Veterans Health Administration), Gabor I. Keitner(Brown University), A. John Rush(The University of Texas Southwestern Medical Center)
Cited by 230
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
|Archives of General Psychiatry|2007|2.4k
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
|Nature Medicine|2016|2.2k
Major depressive disorder
|Nature Reviews Disease Primers|2016|2.1k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k